NSCLC, Stage I Clinical Trials in Catania
2 recruitingCatania, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Lung CancerEGFRNSCLC, Stage IB-IIIA+5 more
Taiho Oncology, Inc.360 enrolled253 locationsNCT07128199
Recruiting
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Non-small Cell Lung CancerNSCLCNSCLC, Stage I+1 more
MSD Italia S.r.l.600 enrolled25 locationsNCT06467383